Boston Scientific Corporation
Clinical trials sponsored by Boston Scientific Corporation, explained in plain language.
A global medical device company specializing in minimally invasive interventions.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New hope for weight loss after GLP-1 failure: Stomach-Sewing procedure tested
Disease control TerminatedThis study looked at whether a procedure called endoscopic sleeve gastroplasty (ESG) could help people with obesity who stopped taking GLP-1 weight loss drugs because of side effects or poor results. Researchers compared weight loss and safety in 18 adults who either had ESG plus…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Varicose vein treatment showdown: foam vs. heat
Symptom relief TerminatedThis study compared two treatments for varicose veins: Varithena (a foam) and Endothermal Ablation (using heat). It included 43 adults with a faulty great saphenous vein. The goal was to see which treatment better reduced symptoms like heaviness and pain over 3 months.
Phase: PHASE4 • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
5-Year check: does this stomach procedure keep weight off?
Knowledge-focused TerminatedThis study looks at people who had an endoscopic sleeve gastroplasty (ESG) at least 5 years ago to see if they kept the weight off. Researchers will measure total body weight loss at the 5-year mark. The goal is to understand the long-term success of this weight-loss procedure.
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC